Osteostimulatory effect of biocomposite scaffold containing phytomolecule diosmin by Integrin/FAK/ERK signaling pathway in mouse mesenchymal stem cells.
S Viji ChandranM VairamaniNagarajan SelvamuruganPublished in: Scientific reports (2019)
Non-availability of an ideal alternative for autografts in treating critical-size bone defects is a major challenge in orthopedics. Phytocompounds have been proven to enhance osteogenesis via various osteogenic signaling pathways, but its decreased bioavailability and increased renal clearance limit its application. In this study, we designed a biocomposite scaffold comprising gelatin (Gel) and nanohydroxyapatite (nHAp) incorporated with diosmin (DM) and we investigated its bone forming potential in vitro and in vivo. Physiochemical characterization of the scaffold showed that DM had no effect on altering the material characteristics of the scaffold. The addition of DM enhanced the osteoblast differentiation potential of the scaffold in mouse mesenchymal stem cells at both cellular and molecular levels, possibly via the integrin-mediated activation of FAK and ERK signaling components. Using the rat tibial bone defective model, we identified the effect of DM in Gel/nHAp scaffold on enhancing bone formation in vivo. Based on our results, we suggest that Gel/nHAp/DM can be a potential therapeutic agent in scaffold-mediated bone regeneration.
Keyphrases
- bone regeneration
- signaling pathway
- tissue engineering
- mesenchymal stem cells
- pi k akt
- bone marrow
- umbilical cord
- bone mineral density
- total knee arthroplasty
- epithelial mesenchymal transition
- hyaluronic acid
- cell proliferation
- soft tissue
- cell migration
- bone loss
- human health
- oxidative stress
- type diabetes
- induced apoptosis
- body composition
- mass spectrometry
- adipose tissue
- climate change
- cell therapy